Influence of agglomeration and specific lung lining lipid/protein interaction on short-term inhalation toxicity

References

• Auffan M, Pedeutour M, Rose J, Masion A, Ziarelli F, Borschneck D, et al. 2010. Structural degradation at the surface of a TiO(2)-based nanomaterial used in cosmetics. Environ Sci Technol 44:2689–94.
   PubMed Web of Science ®Google Scholar
• Barran-Berdon AL, Pozzi D, Caracciolo G, Capriotti AL, Caruso G, Cavaliere C, et al. 2013. Time evolution of nanoparticle-protein corona in human plasma: relevance for targeted drug delivery. Langmuir 29:6485–94.
   PubMed Web of Science ®Google Scholar
• Chen R. 2014. Personal communication with Wohlleben, W.
   Google Scholar
• Chen R, Zhang Y, Darabi Sahneh F, Scoglio CM, Wohlleben W, Haase A, et al. 2014. Nanoparticle surface characterization and clustering through concentration-dependent surface adsorption modeling. ACS Nano 8:9446–56.
   PubMed Web of Science ®Google Scholar
• Creutzenberg O, Bellmann B, Korolewitz R, Koch W, Mangelsdorf I, Tillmann T, et al. 2012. Change in agglomeration status and toxicokinetic fate of various nanoparticles in vivo following lung exposure in rats. Inhal Toxicol 24:821–30.
   PubMed Web of Science ®Google Scholar
• Deloid G, Cohen JM, Darrah T, Derk R, Rojanasakul L, Pyrgiotakis G, et al. 2014. Estimating the effective density of engineered nanomaterials for in vitro dosimetry. Nat Commun 5:3514.
   PubMed Web of Science ®Google Scholar
• Goerke J. 1998. Pulmonary surfactant: functions and molecular composition. Biochim Biophys Acta 1408:79–89.
   PubMed Web of Science ®Google Scholar
• Hellstrand E, Lynch I, Andersson A, Drakenberg T, Dahlback B, Dawson KA, et al. 2009. Complete high-density lipoproteins in nanoparticle corona. FEBS J 276:3372–81.
   PubMed Web of Science ®Google Scholar
• Hirano A, Yoshikawa H, Matsushita S, Yamada Y, Shiraki K. 2012. Adsorption and disruption of lipid bilayers by nanoscale protein aggregates. Langmuir 28:3887–95.
   PubMed Web of Science ®Google Scholar
• Izak-Nau E, Voetz M. 2014. As‐produced: intrinsic physico‐chemical properties and appropriate characterization tools. In: Wohlleben, W, Kuhlbusch TAJ, Lehr C-M, Schnekenburger J, eds. Safety of Nanomaterials Along Their Lifecycle: Release, Exposure and Human Hazards. Boca Raton, FL: Taylor & Francis.
   Google Scholar
• Jiang J, Oberdörster G, Biswas P. 2009. Characterization of size, surface charge, and agglomeration state of nanoparticle dispersions for toxicological studies. J Nanopart Res 11:77–89.
   Web of Science ®Google Scholar
• Johnston H, Pojana G, Zuin S, Jacobsen NR, Moller P, Loft S, et al. 2013. Engineered nanomaterial risk. Lessons learnt from completed nanotoxicology studies: potential solutions to current and future challenges. Crit Rev Toxicol 43:1–20.
   PubMed Web of Science ®Google Scholar
• Kapralov AA, Feng WH, Amoscato AA, Yanamala N, Balasubramanian K, Winnica DE, et al. 2012. Adsorption of surfactant lipids by single-walled carbon nanotubes in mouse lung upon pharyngeal aspiration. ACS Nano 6:4147–56.
   PubMed Web of Science ®Google Scholar
• Klein CL, Wiench K, Wiemann M, Ma-Hock L, Van Ravenzwaay B, Landsiedel R. 2012. Hazard identification of inhaled nanomaterials: making use of short-term inhalation studies. Arch Toxicol 86:1137–51.
   PubMed Web of Science ®Google Scholar
• Landsiedel R, Ma-Hock L, Hofmann T, Wiemann M, Strauss V, Treumann S, et al. 2014. Application of short-term inhalation studies to assess the inhalation toxicity of nanomaterials. Part Fibre Toxicol 11:16
   PubMed Web of Science ®Google Scholar
• Lesniak A, Fenaroli F, Monopoli MP, Aberg C, Dawson KA, Salvati A. 2012. Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells. ACS Nano 6:5845–57.
   PubMed Web of Science ®Google Scholar
• Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson KA. 2008. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci USA 105:14265–70.
   PubMed Web of Science ®Google Scholar
• Maynard AD. 2002. Experimental determination of ultrafine tio2 deagglomeration in a surrogate pulmonary surfactant: preliminary results. Ann Occup Hyg 46:197–202.
   PubMed Web of Science ®Google Scholar
• Montes-Burgos I, Walczyk D, Hole P, Smith J, Lynch I, Dawson KA. 2010. Characterisation of nanoparticle size and state prior to nanotoxicological studies. J Nanopart Res 12:47–53.
   Web of Science ®Google Scholar
• Nel A, Xia T, Madler L, Li N. 2006. Toxic potential of materials at the nanolevel. Science 311:622–7.
   PubMed Web of Science ®Google Scholar
• Oberdorster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, et al. 2005. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol 2:8
   PubMed Web of Science ®Google Scholar
• OECD 2012. Guidance on sample preparation and dosimetry for the safety testing of manufactured nanomaterials. Series on the Safety of Manufactured Nanomaterials Nr. 36. OECD Environment, Health and Safety Publications ENV/JM/MONO(2012)40 Available at: http://www.oecd.org/science/nanosafety/publications-series-safety-manufactured-nanomaterials.htm.
   Google Scholar
• Oosterlaken-Dijksterhuis MA, Van Eijk M, Van Buel BL, Van Golde LM, Haagsman HP. 1991. Surfactant protein composition of lamellar bodies isolated from rat lung. Biochem J 274:115–9.
   PubMed Web of Science ®Google Scholar
• Papageorgiou I, Brown C, Schins R, Singh S, Newson R, Davis S, et al. 2007. The effect of nano- and micron-sized particles of cobalt-chromium alloy on human fibroblasts in vitro. Biomaterials 28:2946–58.
   PubMed Web of Science ®Google Scholar
• Perez-Gil J. 2008. Structure of pulmonary surfactant membranes and films: the role of proteins and lipid-protein interactions. Biochim Biophys Acta 1778:1676–95.
   PubMed Web of Science ®Google Scholar
• Petri-Fink A, Steitz B, Finka A, Salaklang J, Hofmann H. 2008. Effect of cell media on polymer coated superparamagnetic iron oxide nanoparticles (spions): colloidal stability, cytotoxicity, and cellular uptake studies. Eur J Pharm Biopharm 68:129–37.
   PubMed Web of Science ®Google Scholar
• Powers KW, Brown SC, Krishna VB, Wasdo SC, Moudgil BM, Roberts SM. 2006. Research strategies for safety evaluation of nanomaterials. Part vi. Characterization of nanoscale particles for toxicological evaluation. Toxicol Sci 90:296–303.
   PubMed Web of Science ®Google Scholar
• Powers KW, Palazuelos M, Moudgil BM, Roberts SM. 2007. Characterization of the size, shape, and state of dispersion of nanoparticles for toxicological studies. Nanotoxicology 1:42–51.
   Web of Science ®Google Scholar
• Rabilloud T. 2000. Detecting proteins separated by 2-d gel electrophoresis. Anal Chem 72:48A–55A.
   Google Scholar
• Raesch SS, Tenzer S, Storck W, Rurainski A, Selzer D, Ruge CA, et al. 2015. Proteomic and lipidomic analysis of nanoparticle corona upon contact with lung surfactant reveals differences in protein, but not lipid composition. ACS Nano 9:11872–85.
   PubMed Web of Science ®Google Scholar
• Rouser G, Fkeischer S, Yamamoto A. 1970. Two dimensional then layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids 5:494–6.
   PubMed Web of Science ®Google Scholar
• Ruge CA, Driessen MD, Haase A, Schaefer UF, Luch A, Lehr CM. 2014. Analyzing the biological entity of nanomaterials characterization of nanomaterial properties in biological matrices. In: Wohlleben W, Kuhlbusch TAJ, Lehr C-M, Schnekenburger J, eds. Safety of Nanomaterials Along Their Lifecycle: Release, Exposure and Human Hazards. Taylor & Francis.
   Google Scholar
• Ruge CA, Schaefer UF, Herrmann J, Kirch J, Canadas O, Echaide M, et al. 2012. The interplay of lung surfactant proteins and lipids assimilates the macrophage clearance of nanoparticles. PLoS One 7:e40775.
   PubMed Web of Science ®Google Scholar
• Salvati A, Pitek AS, Monopoli MP, Prapainop K, Bombelli FB, Hristov DR, et al. 2013. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nat Nanotechnol 8:137–43.
   PubMed Web of Science ®Google Scholar
• Santhosh PB, Penič S, Genova J, Iglič A, Kralj-Iglič V, Ulrih NP. 2012. A study on the interaction of nanoparticles with lipid membranes and their influence on membrane fluidity. J Phys: Conf Ser 398:012034.
   Google Scholar
• Sayes CM, Warheit DB. 2009. Characterization of nanomaterials for toxicity assessment. Interdiscip Rev Nanomed Nanobiotechnol 1:660–70.
   PubMed Web of Science ®Google Scholar
• Schaefer J, Schulze C, Marxer EE, Schaefer UF, Wohlleben W, Bakowsky U, et al. 2012. Atomic force microscopy and analytical ultracentrifugation for probing nanomaterial protein interactions. ACS Nano 6:4603–14.
   PubMed Web of Science ®Google Scholar
• Schaffler M, Semmler-Behnke M, Sarioglu H, Takenaka S, Wenk A, Schleh C, et al. 2013. Serum protein identification and quantification of the corona of 5, 15 and 80 nm gold nanoparticles. Nanotechnology 24:265103–11.
   PubMed Web of Science ®Google Scholar
• Schleh C, Kreyling WG, Lehr CM. 2013. Pulmonary surfactant is indispensable in order to simulate the in vivo situation. Part Fibre Toxicol 10:6.
   PubMed Web of Science ®Google Scholar
• Schuck P. 2000. Size distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and Lamm equation modeling. Biophys J 78:1606–19.
   PubMed Web of Science ®Google Scholar
• Shelley SA, Paciga JE, Balis JU. 1977. Purification of surfactant from lung washings and washings contaminated with blood constituents. Lipids 12:505–10.
   PubMed Web of Science ®Google Scholar
• Shi T, Schins RPF, Knaapen AM, Kuhlbusch T, Pitz M, Heinrich J, et al. 2003. Hydroxyl radical generation by electron paramagnetic resonance as a new method to monitor ambient particulate matter composition. J Environ Monit 5:550–6.
   PubMed Web of Science ®Google Scholar
• Tenzer S, Docter D, Kuharev J, Musyanovych A, Fetz V, Hecht R, et al. 2013. Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nat Nanotechnol 8:772–81.
   PubMed Web of Science ®Google Scholar
• Tenzer S, Docter D, Rosfa S, Wlodarski A, Kuharev J, Rekik A, et al. 2011. Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis. ACS Nano 5:7155–67.
   PubMed Web of Science ®Google Scholar
• The UniProt Consortium 2015. UniProt: a hub for protein information. Nucleic Acids Res 43:D204–12.
   Google Scholar
• Treuel L, Nienhaus G. 2012. Toward a molecular understanding of nanoparticle–protein interactions. Biophys Rev 4:137–47.
   PubMedGoogle Scholar
• Tyurina YY, Kisin ER, Murray A, Tyurin VA, Kapralova VI, Sparvero LJ, et al. 2011. Global phospholipidomics analysis reveals selective pulmonary peroxidation profiles upon inhalation of single-walled carbon nanotubes. ACS Nano 5:7342–53.
   PubMed Web of Science ®Google Scholar
• Walczyk D, Bombelli FB, Monopoli MP, Lynch I, Dawson KA. 2010. What the cell “sees” in bionanoscience. J Am Chem Soc 132:5761–8.
   PubMed Web of Science ®Google Scholar
• Walkey CD, Chan WC. 2012. Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment. Chem Soc Rev 41:2780–99.
   PubMed Web of Science ®Google Scholar
• Walkey CD, Olsen JB, Song F, Liu R, Guo H, Olsen DW, et al. 2014. Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles. ACS Nano 8:2439–55.
   PubMed Web of Science ®Google Scholar
• Warheit DB. 2008. How meaningful are the results of nanotoxicity studies in the absence of adequate material characterization? Toxicol Sci 101:183–5.
   PubMed Web of Science ®Google Scholar
• Wohlleben W. 2012. Validity range of centrifuges for the regulation of nanomaterials: from classification to as-tested coronas. J Nanopart Res 14:1300.
   PubMed Web of Science ®Google Scholar
• Wohlleben, W, Kuhlbusch T, Lehr C-M, Schnekenburger J., eds. 2014. Safety of Nanomaterials Along their Lifecycle: Release, Exposure and Human Hazards. Boca Raton, FL: Taylor & Francis.
   Google Scholar
• Zhang LW, Monteiro-Riviere NA. 2013. Use of confocal microscopy for nanoparticle drug delivery through skin. J Biomed Opt 18:061214.
   Web of Science ®Google Scholar